PHF2 and metabolic dysfunction-associated steatotic liver disease: However, the regulation of Phf2 activity in hepatocytes and its contribution to the physiopathology of obesity and type 2 diabetes and more specifically to the development and/or progression of NAFLD are currently unknown.